Jones Edward Raymond 5
5 · Cytosorbents Corp · Filed Feb 14, 2019
Insider Transaction Report
Form 5
Jones Edward Raymond
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-31$0.88/sh+1,800$1,575→ 73,600 total - Exercise/Conversion
Common Stock
2018-08-14$2.00/sh+1,200$2,400→ 74,800 total - Exercise/Conversion
Stock Option (right to buy)
2018-05-31−1,800→ 0 totalExercise: $0.88From: 2008-06-25Exp: 2018-06-25→ Common Stock (1,800 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-08-14−1,200→ 0 totalExercise: $2.00From: 2008-12-31Exp: 2018-12-31→ Common Stock (1,200 underlying)
Footnotes (1)
- [F1]Includes (a) the following restricted stock units subject to vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 5,500 shares of common stock owned by the reporting person.